Additionally, Donepezil, a medication primarily used to treat cognitive symptoms in AD, mainly targets and inhibits acetylcholinesterase, an enzyme responsible for the breakdown of acetylcholine in the synaptic cleft [44]. This evidence concerns the gene ACHE and Alzheimer disease.